Leap Therapeutics Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 41
- Published: July 2019
- Report Code: MLPH2503744FSA
Leap Therapeutics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01and TRX518. DKN-0 is a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, hepatocellular carcinoma, prostate cancer and gynecologic cancers. TRX518 is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is in Phase 1 clinical trials intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.
Scope
Detailed information on Leap Therapeutics Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Leap Therapeutics Inc in the form of a SWOT analysis
An in-depth view of the business model of Leap Therapeutics Inc including a breakdown and examination of key business segments
News about Leap Therapeutics Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Leap Therapeutics Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Leap Therapeutics Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Leap Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
TG Therapeutics Inc
Novartis Corp
Incyte Corporation Ltd
Bristol-Myers Squibb Co
Astrazeneca Pty Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.